Myelin protein zero mutation‐related hereditary neuropathies: Neuropathological insight from a new nerve biopsy cohort
Juliane Bremer,Axel Meinhardt,Istvan Katona,Jan Senderek,Elke K. Kämmerer‐Gassler,Andreas Roos,Andreas Ferbert,J. Michael Schröder,Stefan Nikolin,Kay Nolte,Bernd Sellhaus,Klimentina Popzhelyazkova,Frank Tacke,Ulrike Schara‐Schmidt,Eva Neuen‐Jacob,Chantal Ceuterick Groote,Peter Jonghe,Vincent Timmerman,Jonathan Baets,Joachim Weis
DOI: https://doi.org/10.1111/bpa.13200
IF: 7.611
2023-08-17
Brain Pathology
Abstract:To enhance the understanding of subtype‐specific features and pathophysiological aspects of hereditary neuropathies due to mutations in the myelin protein zero (MPZ), we performed neuropathological analyses of archival nerve and muscle biopsies as well as autopsy material and present them along with clinical and genetic data. We confirmed fewer myelinated fibers, more onion bulbs and reduced regeneration in demyelinating Charcot‐Marie‐Tooth (CMT) 1 compared to CMT2/CMTi and observed significantly more denervated Schwann cells, more collagen pockets, fewer unmyelinated axons per Schwann cell unit and a higher density of Schwann cell nuclei in CMT1 compared to CMT2/CMTi. Furthermore, we found prominent neuromatous hyperinnervation of the spinal meninges in the autopsy case and marked structural mitochondrial abnormalities in skeletal muscle, the latter suggesting a peculiar association of MPZ mutations with mitochondrial alterations. Myelin protein zero (MPZ/P0) is a major structural protein of peripheral nerve myelin. Disease‐associated variants in the MPZ gene cause a wide phenotypic spectrum of inherited peripheral neuropathies. Previous nerve biopsy studies showed evidence for subtype‐specific morphological features. Here, we aimed at enhancing the understanding of these subtype‐specific features and pathophysiological aspects of MPZ neuropathies. We examined archival material from two Central European centers and systematically determined genetic, clinical, and neuropathological features of 21 patients with MPZ mutations compared to 16 controls. Cases were grouped based on nerve conduction data into congenital hypomyelinating neuropathy (CHN; n = 2), demyelinating Charcot–Marie‐Tooth (CMT type 1; n = 11), intermediate (CMTi; n = 3), and axonal CMT (type 2; n = 5). Six cases had combined muscle and nerve biopsies and one underwent autopsy. We detected four MPZ gene variants not previously described in patients with neuropathy. Light and electron microscopy of nerve biopsies confirmed fewer myelinated fibers, more onion bulbs and reduced regeneration in demyelinating CMT1 compared to CMT2/CMTi. In addition, we observed significantly more denervated Schwann cells, more collagen pockets, fewer unmyelinated axons per Schwann cell unit and a higher density of Schwann cell nuclei in CMT1 compared to CMT2/CMTi. CHN was characterized by basal lamina onion bulb formation, a further increase in Schwann cell density and hypomyelination. Most late onset axonal neuropathy patients showed microangiopathy. In the autopsy case, we observed prominent neuromatous hyperinnervation of the spinal meninges. In four of the six muscle biopsies, we found marked structural mitochondrial abnormalities. These results show that MPZ alterations not only affect myelinated nerve fibers, leading to either primarily demyelinating or axonal changes, but also affect non‐myelinated nerve fibers. The autopsy case offers insight into spinal nerve root pathology in MPZ neuropathy. Finally, our data suggest a peculiar association of MPZ mutations with mitochondrial alterations in muscle.
pathology,neurosciences,clinical neurology